Fast, Efficient, and Versatile Synthesis of 6-amino-5-carboxamidouracils as Precursors for 8-Substituted Xanthines

被引:16
作者
Marx, Daniel [1 ]
Wingen, Lukas M. [1 ]
Schnakenburg, Gregor [2 ]
Mueller, Christa E. [1 ]
Scholz, zMatthias S. [1 ]
机构
[1] Univ Bonn, Pharmaceut Inst, Pharmaceut Chem 1, Bonn, Germany
[2] Univ Bonn, Inst Inorgan Chem, Dept Chem, Bonn, Germany
关键词
amide; COMU; purine; uracil; xanthine; X-ray crystal structure; ADENOSINE RECEPTOR ANTAGONISTS; A(2A) RECEPTOR; SELECTIVE ANTAGONISTS; DPP-4; INHIBITORS; HIGHLY POTENT; DERIVATIVES; ISTRADEFYLLINE; A(1); A1-ADENOSINE; RADIOLIGAND;
D O I
10.3389/fchem.2019.00056
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Substituted xanthine derivatives are important bioactive molecules. Herein we report on a new, practical synthesis of 6-amino-5-carboxamidouracils, the main building blocks for the preparation of 8-substituted xanthines, by condensation of 5,6-diaminouracil derivatives and various carboxylic acids using the recently developed non-hazardous coupling reagent COMU (1-[(1-(cyano-2-ethoxy-2-oxoethylideneaminooxy)dimethylaminomorpholinomethylene)]methanaminium hexafluoro phosphate). Optimized reaction conditions led to the precipitation of pure products after only 5 to 10 min of reaction time. The method tolerates a variety of substituted 5,6-diaminouracil and carboxylic acid derivatives as starting compounds resulting in most cases in more than 80% isolated yield. Regioselectivity of the reaction yielding only the 5-carboxamido-, but not the 6-carboxamidouracil derivatives, was unambiguously confirmed by single X-ray crystallography and multidimensional NMR experiments. The described method represents a convenient, fast access to direct precursors of 8-substituted xanthines under mild conditions without the necessity of hazardous coupling or chlorinating reagents.
引用
收藏
页数:15
相关论文
共 57 条
[1]  
Alciato P, 1990, Minerva Med, V81, P93
[2]   Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists [J].
Baraldi, PG ;
Tabrizi, MA ;
Preti, D ;
Bovero, A ;
Romagnoli, R ;
Fruttarolo, F ;
Zaid, NA ;
Moorman, AR ;
Varani, K ;
Gessi, S ;
Merighi, S ;
Borea, PA .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (06) :1434-1447
[3]   Novel 8-heterocyclyl xanthine derivatives in drug development - an update [J].
Baraldi, Pier G. ;
Fruttarolo, Francesca ;
Tabrizi, Mojgan A. ;
Romagnoli, Romeo ;
Preti, Delia .
EXPERT OPINION ON DRUG DISCOVERY, 2007, 2 (09) :1161-1183
[4]   Adenosine receptor antagonists: Translating medicinal chemistry and pharmacology into clinical utility [J].
Baraldi, Pier Giovanni ;
Tabrizi, Mojgan Aghazadeh ;
Gessi, Stefania ;
Borea, Pier Andrea .
CHEMICAL REVIEWS, 2008, 108 (01) :238-263
[5]   Design and synthesis of novel xanthine derivatives as potent and selective A2B adenosine receptor antagonists for the treatment of chronic inflammatory airway diseases [J].
Basu, Sujay ;
Barawkar, Dinesh A. ;
Ramdas, Vidya ;
Patel, Meena ;
Waman, Yogesh ;
Panmand, Anil ;
Kumar, Santosh ;
Thorat, Sachin ;
Naykodi, Minakshi ;
Goswami, Arnab ;
Reddy, B. Srinivasa ;
Prasad, Vandna ;
Chaturvedi, Sandhya ;
Quraishi, Azfar ;
Menon, Suraj ;
Paliwal, Shalini ;
Kulkarni, Abhay ;
Karande, Vikas ;
Ghosh, Indraneel ;
Mustafa, Syed ;
De, Siddhartha ;
Jain, Vaibhav ;
Banerjee, Ena Ray ;
Rouduri, Sreekanth R. ;
Palle, Venkata P. ;
Chugh, Anita ;
Mookhtiar, Kasim A. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 134 :218-229
[6]   1-Alkyl-8-(piperazine-1-sulfonyl)phenylxanthines: Development and Characterization of Adenosine A2B Receptor Antagonists and a New Radioligand with Subnanomolar Affinity and Subtype Specificity [J].
Borrmann, Thomas ;
Hinz, Sonja ;
Lertarelli, Daniela C. G. ;
Li, Wenjin ;
Florin, Nicole C. ;
Scheiff, Anja B. ;
Mueller, Christa E. .
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (13) :3994-4006
[7]   Adenosine receptors as drug targets - what are the challenges? [J].
Chen, Jiang-Fan ;
Eltzschig, Holger K. ;
Fredholm, Bertil B. .
NATURE REVIEWS DRUG DISCOVERY, 2013, 12 (04) :265-286
[8]   Structures of Human A1 and A2A Adenosine Receptors with Xanthines Reveal Determinants of Selectivity [J].
Cheng, Robert K. Y. ;
Segala, Elena ;
Robertson, Nathan ;
Deflorian, Francesca ;
Dore, Andrew S. ;
Errey, James C. ;
Errey, James C. ;
Fiez-Vandal, Cedric ;
Marshall, Fiona H. ;
Cooke, Robert M. .
STRUCTURE, 2017, 25 (08) :1275-+
[9]   DPP-4 inhibitors: a patent review (2012-2014) [J].
Costante, Roberto ;
Stefanucci, Azzurra ;
Carradori, Simone ;
Novellino, Ettore ;
Mollica, Adriano .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2015, 25 (02) :209-236
[10]   Dipeptidyl peptidase 4 (DPP-4) inhibitors and their role in Type 2 diabetes management [J].
Crepaldi, G. ;
Carruba, M. ;
Comaschi, M. ;
Del Prato, S. ;
Frajese, G. ;
Paolisso, G. .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2007, 30 (07) :610-614